Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option

Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S100-S102. doi: 10.21037/tlcr.2018.02.09.

Authors

Antonio Passaro¹, Filippo de Marinis¹

Affiliation

¹ Division of Thoracic Oncology, European Institute of Oncology, IEO, Milan, Italy.

No abstract available

Publication types

Editorial
Comment